Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity
Erwan Pernet1, Laurent Guillemot2, Pierre-Régis Burgel3
11] Unité de défense innée et inflammation, Institut Pasteur, 75015 Paris, France [2] INSERM U874, 75015 Paris, France [3] Université Pierre et Marie Curie, Cellule Pasteur UPMC, rue du Dr Roux, 75015 Paris, France.
Pseudomonas aeruginosa triggers the host enzyme secretory phospholipase A2 (sPLA2-IIA) to eliminate Staphylococcus aureus in cystic fibrosis (CF) airways. This highlights how one bacterium can manipulate host immunity to eradicate another.
Area of Science:
- Host-pathogen interactions in cystic fibrosis
- Microbial ecology of the airways
- Innate immune responses to bacterial infections
Background:
- Cystic fibrosis (CF) patients experience shifts in airway bacterial colonization, from Staphylococcus aureus in youth to Pseudomonas aeruginosa in adulthood.
- The underlying mechanisms driving this transition in dominant bacterial species remain largely unknown.
- Understanding these dynamics is crucial for developing effective CF treatment strategies.
Purpose of the Study:
- To investigate the role of host-derived secretory phospholipase A2 type IIA (sPLA2-IIA) in the age-dependent shift of bacterial colonization in CF airways.
- To determine the differential effects of sPLA2-IIA on S. aureus and P. aeruginosa.
- To elucidate the mechanisms by which P. aeruginosa influences sPLA2-IIA production.
Main Methods:
- Quantification of sPLA2-IIA levels in CF patient expectorations across different age groups.
- In vitro assessment of sPLA2-IIA's bactericidal activity against S. aureus and P. aeruginosa.
- Analysis of sPLA2-IIA expression in CF bronchial epithelial cells stimulated by P. aeruginosa.
- In vivo evaluation of P. aeruginosa-induced sPLA2-IIA production in a murine lung infection model.
Main Results:
- sPLA2-IIA levels significantly increase with age in CF patient expectorations.
- sPLA2-IIA demonstrates potent bactericidal activity against S. aureus but has minimal impact on P. aeruginosa.
- P. aeruginosa actively induces sPLA2-IIA expression in CF bronchial epithelial cells and in vivo, promoting S. aureus clearance.
Conclusions:
- P. aeruginosa-induced sPLA2-IIA production contributes to the eradication of S. aureus in CF airways.
- This study reveals a novel mechanism where a pathogen manipulates host immunity to eliminate competing bacteria.
- Findings suggest sPLA2-IIA as a potential therapeutic target for modulating airway microbiota in CF.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Microbial Interactions: Parasitism


